Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue ...

Charles River Laboratories on Wednesday raised its annual profit forecast, betting on growing demand for its drug discovery and development services from drugmakers, sending its shares up more than 4% ...

Charles River Laboratories' annual profit forecast raise on Wednesday was clouded by investor concerns about the higher number of order cancellations from clients, sending the contract research firm's ...

Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...

Second-Quarter GAAP Earnings per Share of $1.06 and Non-GAAP Earnings per Share of $3.12 – – Updates 2025 Guidance – WILM ...

Investing.com -- Charles River Laboratories International, Inc. (NYSE: CRL) shares jumped 6.9% after the company reported second-quarter earnings on Wednesday that significantly exceeded analyst ...

A Relative Strength Rating upgrade for Caris Life Sciences shows improving technical performance. Will it continue?

The S&P 500 Index ($SPX) (SPY) today is up +0.44%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.26%, and the Nasdaq ...

Good morning, and welcome to the MannKind Corporation Second Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded on August 6, 2025, and will be available for ...

Despite the earnings miss, MetLife saw 5% growth in adjusted premiums, fees and other revenues excluding pension risk transfers, which rose to $12.4 billion. Net investment income increased 9% to $5.7 ...

The Kerala High Court closed the contempt proceedings initiated against former MLA R Rajesh by allowing a discharge ...